201 related articles for article (PubMed ID: 15681595)
1. Long-term nicotine treatment decreases striatal alpha 6* nicotinic acetylcholine receptor sites and function in mice.
Lai A; Parameswaran N; Khwaja M; Whiteaker P; Lindstrom JM; Fan H; McIntosh JM; Grady SR; Quik M
Mol Pharmacol; 2005 May; 67(5):1639-47. PubMed ID: 15681595
[TBL] [Abstract][Full Text] [Related]
2. Loss of nicotinic receptors in monkey striatum after 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine treatment is due to a decline in alpha-conotoxin MII sites.
Kulak JM; McIntosh JM; Quik M
Mol Pharmacol; 2002 Jan; 61(1):230-8. PubMed ID: 11752225
[TBL] [Abstract][Full Text] [Related]
3. Differential declines in striatal nicotinic receptor subtype function after nigrostriatal damage in mice.
Quik M; Sum JD; Whiteaker P; McCallum SE; Marks MJ; Musachio J; McIntosh JM; Collins AC; Grady SR
Mol Pharmacol; 2003 May; 63(5):1169-79. PubMed ID: 12695545
[TBL] [Abstract][Full Text] [Related]
4. Differential regulation of mesolimbic alpha 3/alpha 6 beta 2 and alpha 4 beta 2 nicotinic acetylcholine receptor sites and function after long-term oral nicotine to monkeys.
McCallum SE; Parameswaran N; Bordia T; Fan H; McIntosh JM; Quik M
J Pharmacol Exp Ther; 2006 Jul; 318(1):381-8. PubMed ID: 16622038
[TBL] [Abstract][Full Text] [Related]
5. UB-165: a novel nicotinic agonist with subtype selectivity implicates the alpha4beta2* subtype in the modulation of dopamine release from rat striatal synaptosomes.
Sharples CG; Kaiser S; Soliakov L; Marks MJ; Collins AC; Washburn M; Wright E; Spencer JA; Gallagher T; Whiteaker P; Wonnacott S
J Neurosci; 2000 Apr; 20(8):2783-91. PubMed ID: 10751429
[TBL] [Abstract][Full Text] [Related]
6. Different nicotinic acetylcholine receptor subtypes mediating striatal and prefrontal cortical [3H]dopamine release.
Cao YJ; Surowy CS; Puttfarcken PS
Neuropharmacology; 2005 Jan; 48(1):72-9. PubMed ID: 15617729
[TBL] [Abstract][Full Text] [Related]
7. Selective down-regulation of [(125)I]Y0-alpha-conotoxin MII binding in rat mesostriatal dopamine pathway following continuous infusion of nicotine.
Mugnaini M; Garzotti M; Sartori I; Pilla M; Repeto P; Heidbreder CA; Tessari M
Neuroscience; 2006; 137(2):565-72. PubMed ID: 16289885
[TBL] [Abstract][Full Text] [Related]
8. A novel α-conotoxin MII-sensitive nicotinic acetylcholine receptor modulates [(3) H]-GABA release in the superficial layers of the mouse superior colliculus.
McClure-Begley TD; Wageman CR; Grady SR; Marks MJ; McIntosh JM; Collins AC; Whiteaker P
J Neurochem; 2012 Jul; 122(1):48-57. PubMed ID: 22506481
[TBL] [Abstract][Full Text] [Related]
9. Long-term nicotine treatment differentially regulates striatal alpha6alpha4beta2* and alpha6(nonalpha4)beta2* nAChR expression and function.
Perez XA; Bordia T; McIntosh JM; Grady SR; Quik M
Mol Pharmacol; 2008 Sep; 74(3):844-53. PubMed ID: 18583454
[TBL] [Abstract][Full Text] [Related]
10. L-DOPA treatment modulates nicotinic receptors in monkey striatum.
Quik M; Bordia T; Okihara M; Fan H; Marks MJ; McIntosh JM; Whiteaker P
Mol Pharmacol; 2003 Sep; 64(3):619-28. PubMed ID: 12920198
[TBL] [Abstract][Full Text] [Related]
11. Decrease in alpha3*/alpha6* nicotinic receptors but not nicotine-evoked dopamine release in monkey brain after nigrostriatal damage.
McCallum SE; Parameswaran N; Bordia T; McIntosh JM; Grady SR; Quik M
Mol Pharmacol; 2005 Sep; 68(3):737-46. PubMed ID: 15933214
[TBL] [Abstract][Full Text] [Related]
12. Chronic nicotine differentially regulates alpha6- and beta3-containing nicotinic cholinergic receptors in rat brain.
Perry DC; Mao D; Gold AB; McIntosh JM; Pezzullo JC; Kellar KJ
J Pharmacol Exp Ther; 2007 Jul; 322(1):306-15. PubMed ID: 17446303
[TBL] [Abstract][Full Text] [Related]
13. Effects of nicotine in the dopaminergic system of mice lacking the alpha4 subunit of neuronal nicotinic acetylcholine receptors.
Marubio LM; Gardier AM; Durier S; David D; Klink R; Arroyo-Jimenez MM; McIntosh JM; Rossi F; Champtiaux N; Zoli M; Changeux JP
Eur J Neurosci; 2003 Apr; 17(7):1329-37. PubMed ID: 12713636
[TBL] [Abstract][Full Text] [Related]
14. Pharmacology of alpha-conotoxin MII-sensitive subtypes of nicotinic acetylcholine receptors isolated by breeding of null mutant mice.
Salminen O; Drapeau JA; McIntosh JM; Collins AC; Marks MJ; Grady SR
Mol Pharmacol; 2007 Jun; 71(6):1563-71. PubMed ID: 17341654
[TBL] [Abstract][Full Text] [Related]
15. Subunit composition and pharmacology of two classes of striatal presynaptic nicotinic acetylcholine receptors mediating dopamine release in mice.
Salminen O; Murphy KL; McIntosh JM; Drago J; Marks MJ; Collins AC; Grady SR
Mol Pharmacol; 2004 Jun; 65(6):1526-35. PubMed ID: 15155845
[TBL] [Abstract][Full Text] [Related]
16. Differential inhibition by alpha-conotoxin-MII of the nicotinic stimulation of [3H]dopamine release from rat striatal synaptosomes and slices.
Kaiser SA; Soliakov L; Harvey SC; Luetje CW; Wonnacott S
J Neurochem; 1998 Mar; 70(3):1069-76. PubMed ID: 9489727
[TBL] [Abstract][Full Text] [Related]
17. Increases in alpha4* but not alpha3*/alpha6* nicotinic receptor sites and function in the primate striatum following chronic oral nicotine treatment.
McCallum SE; Parameswaran N; Bordia T; Fan H; Tyndale RF; Langston JW; McIntosh JM; Quik M
J Neurochem; 2006 Feb; 96(4):1028-41. PubMed ID: 16412091
[TBL] [Abstract][Full Text] [Related]
18. Subunit composition of nicotinic receptors in monkey striatum: effect of treatments with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine or L-DOPA.
Quik M; Vailati S; Bordia T; Kulak JM; Fan H; McIntosh JM; Clementi F; Gotti C
Mol Pharmacol; 2005 Jan; 67(1):32-41. PubMed ID: 15470079
[TBL] [Abstract][Full Text] [Related]
19. 5-Iodo-A-85380 binds to alpha-conotoxin MII-sensitive nicotinic acetylcholine receptors (nAChRs) as well as alpha4beta2* subtypes.
Kulak JM; Sum J; Musachio JL; McIntosh JM; Quik M
J Neurochem; 2002 Apr; 81(2):403-6. PubMed ID: 12064487
[TBL] [Abstract][Full Text] [Related]
20. Expression of nigrostriatal alpha 6-containing nicotinic acetylcholine receptors is selectively reduced, but not eliminated, by beta 3 subunit gene deletion.
Gotti C; Moretti M; Clementi F; Riganti L; McIntosh JM; Collins AC; Marks MJ; Whiteaker P
Mol Pharmacol; 2005 Jun; 67(6):2007-15. PubMed ID: 15749993
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
